We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RPTX market cap is 130.51M. The company's latest EPS is USD -2.2064 and P/E is -1.26.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Total Revenue | 30.25M | 2.16M | 13.05M | 52.4M | 2.06M |
| Operating Income | -12.26M | -38.42M | -30.87M | 10.82M | -37.32M |
| Net Income | -11.95M | -18.88M | -28.03M | 13.16M | -34.77M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Revenue | 135k | 7.6M | 131.83M | 51.13M |
| Operating Income | -54.3M | -108.66M | -19.8M | -116.22M |
| Net Income | -53.42M | -106.91M | -29.05M | -93.8M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Total Assets | 301.59M | 286.41M | 253.9M | 263.08M | 235.34M |
| Total Liabilities | 56.17M | 53.04M | 41.82M | 31.13M | 31.67M |
| Total Equity | 245.41M | 233.37M | 212.08M | 231.95M | 203.68M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Total Assets | 357.09M | 368.72M | 364.08M | 253.9M |
| Total Liabilities | 70.26M | 80.29M | 84.56M | 41.82M |
| Total Equity | 286.83M | 288.42M | 279.52M | 212.08M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | ||
| Operating | -66.13M | -99M | -127.16M | 11.93M | -18.58M |
| Investing | 21.66M | 46.16M | 78.04M | -20.32M | -13.2M |
| Financing | 453k | 737k | 842k | 375k | 375k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | |
| Operating | -6.08M | -85.8M | 322k | -127.16M |
| Investing | -9.76M | -1.68M | -175.78M | 78.04M |
| Financing | 247.84M | 95.56M | 880k | 842k |
| Market Cap | 130.51M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 2.32 |
| Price to Cash Ratio | 1.07 |
| Price to Book Ratio | 0.56 |
| Dividend Yield | - |
| Shares Outstanding | 42.51M |
| Average Volume (1 week) | 209.15k |
| Average Volume (1 Month) | 116.24k |
| 52 Week Change | -36.31% |
| 52 Week High | 8.49 |
| 52 Week Low | 2.71 |
| Spread (Intraday) | 2.23 (44.78%) |
| Company Name | Repare Therapeutics Inc |
| Address |
7210 frederick-banting street saint-laurent, quebec H4S 2A1 |
| Website | https://www.reparerx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
